← Back
Data updated: Mar 10, 2026
UMEDICA
CardiovascularImmunologyNeurology
UMEDICA is a generic drug manufacturer focused on Cardiovascular, Immunology, Neurology. Key products include SERTRALINE HYDROCHLORIDE.
2018
Since
17
Drugs
-
Trials
304
Approved (2yr)
Recent Activity
EFINACONAZOLE 2026-02-23
CELECOXIB 2026-02-12
Labeling
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
ATORVASTATIN CALCIUM 2026-01-22
Manufacturing (CMC)
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 51%
3 drugs Phase 1: 1
Immunology 32%
2 drugs
Neurology 16%
1 drugs
Pipeline Strength Pro
Loading...
Active (13)
Discontinued (3)
Company Info
- First Approval
- 2018-05-24
- Latest
- 2026-01-20
- Applications
- 19